BRIDGEWAY CAPITAL MANAGEMENT, LLC - APPLIED GENETIC TECHNOL CORP ownership

APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 91 filers reported holding APPLIED GENETIC TECHNOL CORP in Q4 2016. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of APPLIED GENETIC TECHNOL CORP
ValueSharesWeighting
Q2 2022$120,000
-34.1%
155,375
-8.5%
0.00%
-25.0%
Q1 2022$182,000
-43.7%
169,9000.0%0.00%
-33.3%
Q4 2021$323,000
-45.3%
169,900
-13.3%
0.01%
-45.5%
Q3 2021$590,000
-23.0%
195,9000.0%0.01%
-21.4%
Q2 2021$766,000
+30.3%
195,900
+69.0%
0.01%
+27.3%
Q1 2021$588,000
+24.1%
115,9000.0%0.01%
+10.0%
Q4 2020$474,000
-15.8%
115,9000.0%0.01%
-23.1%
Q3 2020$563,000
-12.3%
115,9000.0%0.01%0.0%
Q2 2020$642,000
+142.3%
115,900
+43.3%
0.01%
+116.7%
Q1 2020$265,000
-43.3%
80,900
-21.7%
0.01%0.0%
Q4 2019$467,000
+8.6%
103,3000.0%0.01%0.0%
Q3 2019$430,000
+9.7%
103,3000.0%0.01%
+20.0%
Q2 2019$392,000
+12.3%
103,300
+24.0%
0.01%
+25.0%
Q1 2019$349,000
+10.8%
83,300
-34.3%
0.00%0.0%
Q4 2018$315,000
-65.9%
126,7000.0%0.00%
-55.6%
Q3 2018$925,000
+64.9%
126,700
-16.5%
0.01%
+50.0%
Q2 2018$561,000
+50.8%
151,700
+56.9%
0.01%
+50.0%
Q1 2018$372,000
+11.7%
96,700
+4.7%
0.00%0.0%
Q4 2017$333,000
-8.8%
92,4000.0%0.00%0.0%
Q3 2017$365,000
-22.5%
92,4000.0%0.00%
-33.3%
Q2 2017$471,000
-49.5%
92,400
-31.6%
0.01%
-45.5%
Q1 2017$932,000
+121.4%
135,000
+200.0%
0.01%
+120.0%
Q4 2016$421,00045,0000.01%
Other shareholders
APPLIED GENETIC TECHNOL CORP shareholders Q4 2016
NameSharesValueWeighting ↓
INTERWEST VENTURE MANAGEMENT CO 1,455,904$7,075,0002.04%
DAFNA Capital Management LLC 1,095,139$5,322,0001.73%
Portolan Capital Management 1,301,075$6,323,0000.72%
Sofinnova Investments, Inc. 825,071$4,010,0000.30%
Ikarian Capital, LLC 545,884$2,654,0000.19%
683 Capital Management, LLC 364,299$1,770,0000.13%
Gyon Technologies Capital Management, LP 18,653$91,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 336,900$1,637,0000.07%
HighVista Strategies LLC 15,200$74,0000.05%
PURA VIDA INVESTMENTS, LLC 176,411$857,0000.04%
View complete list of APPLIED GENETIC TECHNOL CORP shareholders